GSK plc (LON:GSK)
1,628.00
-9.50 (-0.58%)
Oct 15, 2025, 4:47 PM BST
GSK plc Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
460.90K GBP
Profits / Employee
49.88K GBP
Market Cap
65.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
Dec 31, 2023 | 70,212 | 812 | 1.17% |
Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Oxford Nanopore Technologies | 1,382 |
GSK plc News
- 3 hours ago - Pfizer (PFE) and GSK's ViiV Shows Promising HIV Therapy Results - GuruFocus
- 3 hours ago - SCYNEXIS (SCYX) Secures $22 Million from GlaxoSmithKline Settlement - GuruFocus
- 5 hours ago - GSK chief doesn’t buy that the CEO role has become unsustainable: ‘There are few things more obnoxious in life than CEOs complaining about how hard their life is’ - Fortune
- 1 day ago - Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Benzinga
- 1 day ago - GSK Secures Approval for Shingles Vaccine Shingrix in China - GuruFocus
- 1 day ago - GSK gets China nod for Shingrix to prevent shingles in adults aged 18+ - Seeking Alpha
- 1 day ago - GSK Receives China Approval for Shingrix to Prevent Shingles in At-Risk Adults - GuruFocus
- 1 day ago - Unilever’s £15bn Bid for GSK Consumer Health Ignites FTSE Frenzy, Shares Soar 4% on Deal Speculation - ABC Money